1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. BETA BIONICS INC.

Beta Bionics Inc.

XNAS: BBNX

Download real time

15.79 -0.03 (-0.19%)

35.55% Fall from 52W High

472.4K XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
2S
7W
1O
0T
684.2

Market Cap

Below industry Median
-

PE TTM

-

PEG TTM

-3

Price to Book

Negative Price to Book
-

Beta 1Year



Insider Trading disclosures for Beta Bionics Inc.

The latest disclosure was made by Christy Jones in Beta Bionics Inc. where a trade of 11,247 Common Stock done was reported to US exchanges on March 15, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Christy Jones Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 11,247 11,247 - 0 Common Stock
Adam Lezack Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 11,247 11,247 - 0 Common Stock
Maria Palasis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 11,247 11,247 - 0 Common Stock
Danny L. Dearen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 11,247 11,247 - 0 Common Stock
Sean D. Carney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 11,247 11,247 - 0 Common Stock
Stephen Feider Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 47,000 47,000 - 0 Common Stock
Sean Saint Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 163,000 163,000 - - Employee Stock Option (right to buy)
Sean Saint Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 108,000 108,000 - 0 Common Stock
Stephen Feider Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 71,000 71,000 - - Employee Stock Option (right to buy)
Mike Mensinger Chief Product Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 52,000 52,000 - - Employee Stock Option (right to buy)
Mike Mensinger Chief Product Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 35,000 94,019 - 0 Common Stock
Steven Russell Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 35,000 73,071 - 0 Common Stock
Steven Russell Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 52,000 52,000 - - Employee Stock Option (right to buy)
Mark Hopman Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 52,000 52,000 - - Employee Stock Option (right to buy)
Mark Hopman Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 35,000 35,000 - 0 Common Stock
Steven Russell Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 90,637 90,637 - - Employee Stock Option (right to buy)
Mark Hopman Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 47,775 47,775 - - Employee Stock Option (right to buy)
Mark Hopman Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 39,424 39,424 - - Employee Stock Option (right to buy)
Mark Hopman Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 37,229 37,229 - - Employee Stock Option (right to buy)
Mark Hopman Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 83,242 83,242 - - Employee Stock Option (right to buy)
Mark Hopman Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 17,765 17,765 - - Employee Stock Option (right to buy)
Christy Jones Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 9,137 9,137 - - Director Stock Option (right to buy)
Christy Jones Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 48,730 48,730 - - Director Stock Option (right to buy)
Christy Jones Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 9,137 9,137 - - Director Stock Option (right to buy)
Adam Lezack Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 9,137 9,137 - - Director Stock Option (right to buy)
Steven Russell Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 53,584 53,584 - - Employee Stock Option (right to buy)
Steven Russell Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 81,217 81,217 - - Employee Stock Option (right to buy)
Sean D. Carney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 30,456 30,456 - - Director Stock Option (right to buy)
Sean D. Carney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 55,837 55,837 - - Director Stock Option (right to buy)
Maria Palasis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 9,137 9,137 - - Director Stock Option (right to buy)
Sean Saint Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 467,944 467,944 - - Employee Stock Option (right to buy)
Sean Saint Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 54,911 54,911 - - Employee Stock Option (right to buy)
Sean Saint Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 494,198 494,198 - - Employee Stock Option (right to buy)
Sean Saint Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 83,268 83,268 - - Employee Stock Option (right to buy)
Sean Saint Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 749,445 749,445 - - Employee Stock Option (right to buy)
Stephen Feider Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 166,542 166,542 - - Employee Stock Option (right to buy)
Stephen Feider Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 186,203 186,203 - - Employee Stock Option (right to buy)
Stephen Feider Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 109,695 109,695 - - Employee Stock Option (right to buy)
Mike Mensinger Chief Product Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 110,278 110,278 - - Employee Stock Option (right to buy)
Mike Mensinger Chief Product Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 236,553 236,553 - - Employee Stock Option (right to buy)
Mike Mensinger Chief Product Officer 31 Jan 2025 10,575 0 - - Class B Common Stock Warrant (right to buy)
Mike Mensinger Chief Product Officer 31 Jan 2025 10,575 10,575 - - Class B Common Stock Warrant (right to buy)
Mike Mensinger Chief Product Officer 31 Jan 2025 15,107 0 - - Series D Preferred Stock
Mike Mensinger Chief Product Officer Purchase of securities on an exchange or from another person at price $ 17.00 per share. 31 Jan 2025 33,350 59,019 - 17 566,950 Common Stock
Mike Mensinger Chief Product Officer Sale of securities on an exchange or to another person at price $ 17.00 per share. 31 Jan 2025 13 25,669 - 17 221 Common Stock
Mike Mensinger Chief Product Officer 31 Jan 2025 10,575 25,682 - 0.0 212 Common Stock
Mike Mensinger Chief Product Officer 31 Jan 2025 15,107 15,107 - - Common Stock
Sean Saint Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2025 467,944 467,944 - - Employee Stock Option (right to buy)
Mark Hopman Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2025 47,775 47,775 - - Employee Stock Option (right to buy)
Steven Russell Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2025 90,637 90,637 - - Employee Stock Option (right to buy)
Mike Mensinger Chief Product Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2025 110,278 110,278 - - Employee Stock Option (right to buy)
Stephen Feider Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2025 186,203 186,203 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters